Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1991-08-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0006-291X(91)91335-APMID 1883391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.

  1991cited by this paper
• Cloning, sequencing and expression of human TSH receptor.

  1990cited by this paper
• Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies.

  1990cited by this paper
• Identification of immunogenic regions in human thyrotropin receptor for immunoglobulin G of patients with Graves' disease.

  1990cited by this paper
• Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding.

  1990cited by this paper
• The thyroid as a model endocrine system.

  1989cited by this paper
• Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family.

  1989cited by this paper
• Sequence and chromosomal assignment of a novel cDNA identified by immunoscreening of a thyroid expression library: similarity to a family of mitochondrial solute carrier proteins.

  1989cited by this paper
• Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor.

  1989cited by this paper
• Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies.

  1989cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• Monoclonal antibodies to the thyrotropin receptor bind to a 56-kDa subunit of the thyrotropin receptor and show heterogeneous bioactivities.

  1988cited by this paper
• Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.

  1988cited by this paper
• Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.

  1988cited by this paper
• Monoclonal Antibody Studies Defining the Origin and Properties of Autoantibodies in Graves' Disease

  1986cited by this paper
• A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3',5'-monophosphate increase.

  1982cited by this paper

• Bioassays for thyrotropin receptor autoantibodies.

  2023cites this paper
• The role of the laboratory medicine in the diagnosis of the hyperthyroidism.

  2021cites this paper
• Comparison of a Novel Homogeneous Cyclic Amp Assay and a Luciferase Assay for Measuring Stimulating Thyrotropin-Receptor Autoantibodies

  2019cites this paper
• Comparison of a Bridge Immunoassay with Two Bioassays for Thyrotropin Receptor Antibody Detection and Differentiation

  2019influential citation
• Thyroid Stimulating Hormone Receptor Antibodies in Thyroid Eye Disease-Methodology and Clinical Applications.

  2018cites this paper
• Analytical and Clinical Validation of Two Commercially Available Immunoassays Used in the Detection of TSHR Antibodies.

  2017cites this paper
• Bioassays for TSH Receptor Autoantibodies, from FRTL-5 Cells to TSH Receptor–LH/CG Receptor Chimeras: The Contribution of Leonard D. Kohn

  2016cites this paper
• High cut-off value of a chimeric TSH receptor (Mc4)-based bioassay may improve prediction of relapse in Graves’ disease for 12 months

  2015cites this paper
• Bridge Technology with TSH Receptor Chimera for Sensitive Direct Detection of TSH Receptor Antibodies Causing Graves’ Disease: Analytical and Clinical Evaluation

  2015cites this paper
• Characterization of Former Gestational Diabetes Mellitus: Prognostic, Therapeutic, and Predictive Aspects

  2012cites this paper
• A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.

  2012cites this paper
• Gestational Diabetes and Thyroid Autoimmunity

  2012cites this paper
• Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.

  2012cites this paper
• Targeting the thyrotropin receptor in thyroid disease

  2012cites this paper
• A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment.

  2012cites this paper
• A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor.

  2011cites this paper
• Autoimmune Alternating Hypo- and Hyperthyroidism in Children

  2011cites this paper
• Similar Clinical Performance of a Novel Chimeric Thyroid-Stimulating Hormone Receptor Bioassay and an Automated Thyroid-Stimulating Hormone Receptor Binding Assay in Graves' Disease

  2011cites this paper
• Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.

  2011cites this paper
• A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.

  2010cites this paper
• Comparison of a Novel Cell-based Reporter Assay and a Competitive Binding ELISA for the Detection of Thyrotropin-Receptor (TSHR) Autoantibodies (TRAb) in Graves’ Disease Patients

  2010influential citation
• A Novel Bioreporter Assay for Thyrotropin Receptor Antibodies Using a Chimeric Thyrotropin Receptor (Mc4) Is More Useful in Differentiation of Graves' Disease from Painless Thyroiditis Than Conventional Thyrotropin-Stimulating Antibody Assay Using Porcine Thyroid Cells

  2010cites this paper
• Techniques to quantify TSH receptor antibodies

  2008cites this paper
• Targeted Expression of the Human Thyrotropin Receptor A-Subunit to the Mouse Thyroid: Insight into Overcoming the Lack of Response to A-Subunit Adenovirus Immunization1

  2006cites this paper
• Biolog Peptid ical Activities of Rat Antisera Raised es of Human Thyrotropin Receptor against Synthetic

  2006cites this paper
• Recent Progress Concept of "Aut in TSH Receptor Studies oimmune TSH Receptor with a New Disease"

  2006cites this paper
• TSH Receptor and LH Receptor,

  2006cites this paper
• Thyrotropin receptor antibodies: new insights into their actions and clinical relevance.

  2005cites this paper
• Immunization Lack of Response to A-Subunit Adenovirus Mouse Thyroid : Insight into Overcoming the Thyrotropin Receptor A-Subunit to the Targeted Expression of the Human and

  2005cites this paper
• Insight into Graves' hyperthyroidism from animal models.

  2005cites this paper
• Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data.

  2005cites this paper
• Thyrotropin receptor autoantibodies in Graves' disease.

  2005cites this paper
• A coated tube assay for the detection of blocking thyrotropin receptor autoantibodies.

  2004cites this paper
• Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity.

  2004cites this paper
• Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit.

  2004cites this paper
• Antibodies to TSH‐receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor

  2004cites this paper
• Dynamics of thyroid-stimulating and -blocking antibodies to the thyrotropin receptor in a murine model of Graves' disease.

  2004cites this paper
• Dissecting linear and conformational epitopes on the native thyrotropin receptor.

  2004cites this paper
• Evidence for two discontinuous regions on the thyrotropin receptor involved in the binding of the monoclonal antibody 34A

  2004cites this paper
• Immunity to the thyroid-stimulating hormone receptor

  2004cites this paper
• Epitope heterogeneity of thyroid-stimulating antibodies predicts long-term outcome in Graves' patients treated with antithyroid drugs.

  2003cites this paper
• The Effect of Thyrotropin-Receptor Blocking Antibodies on Stimulating Autoantibodies from Patients with Graves' Disease

  2003cites this paper
• This information is current as Experimental Autoimmune Graves ' Disease Th 2 Response , Prevents Development of Absence of IL-4 , and Not Suppression of the Holterman and Bellur

  2003cites this paper
• The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors.

  2003cites this paper
• Absence of IL-4, and Not Suppression of the Th2 Response, Prevents Development of Experimental Autoimmune Graves’ Disease 1

  2003cites this paper
• Thyrotropin Receptor Autoantibodies (TSHRAbs): Epitopes, Origins and Clinical Significance

  2003cites this paper
• A method for identification of the peptides that bind to a clone of thyroid-stimulating antibodies in the serum of Graves' disease patients.

  2003cites this paper
• Monoclonal Antibodies with Thyroid Stimulating Activity, at Last

  2002cites this paper
• Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist.

  2002cites this paper
• Involvement of the protein kinase C pathway in thyrotropin-induced STAT3 activation in FRTL-5 thyroid cells.

  2002cites this paper
• Clinical applications of TSH receptor antibodies in thyroid diseases.

  2002cites this paper
• Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.

  2002cites this paper
• A Novel Murine Model of Graves’ Hyperthyroidism with Intramuscular Injection of Adenovirus Expressing the Thyrotropin Receptor

  2002cites this paper
• Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin.

  2002cites this paper
• Evidence for a Simplified View of Autoantibody Interactions with the Thyrotropin Receptor

  2002cites this paper
• Thyrotropin Receptor Injection of Adenovirus Expressing the Hyperthyroidism with Intramuscular A Novel Murine Model of Graves'

  2002cites this paper
• Thyroid autoimmunity.

  2001cites this paper
• Antithyrotropin Receptor Antibody: An Update

  2001cites this paper
• Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action

  2001cites this paper
• Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.

  2001cites this paper
• Studies using recombinant fragments of human TSH receptor reveal apparent diversity in the binding specificities of antibodies that block TSH binding to its receptor or stimulate thyroid hormone production.

  2001cites this paper
• Clinical Significance of Classification of Graves’ Disease According to the Characteristics of TSH Receptor Antibodies

  2001cites this paper
• A Full Biological Response to Autoantibodies in Graves' Disease Requires a Disulfide-bonded Loop in the Thyrotropin Receptor N Terminus Homologous to a Laminin Epidermal Growth Factor-like Domain*

  2001cites this paper
• Reassessment of the Location of the Thyrotropin Receptor 50 Amino Acid "Insertion" Provides Evidence in Favor of a Second Downstream Cleavage Site

  2001cites this paper
• The Prevalence and Clinical Significance of Blocking Thyrotropin Receptor Antibodies in Untreated Hyperthyroid Graves' Disease

  2000cites this paper
• Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.

  2000cites this paper
• Thyrotropin-receptor antibodies in thyroid diseases: advances in detection techniques and clinical applications.

  2000cites this paper
• Characterization of Thyroid-Stimulating Blocking Antibodies That Appeared During Transient Hypothyroidism After Radioactive Iodine Therapy

  2000cites this paper
• Thyroid Autoantibodies in Graves’ Disease

  2000cites this paper
• Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.

  2000cites this paper
• Induction of experimental autoimmune Graves' disease in BALB/c mice.

  1999cites this paper
• Graves' Disease in BALB/c Mice Induction of Experimental Autoimmune

  1999cites this paper
• Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.

  1999cites this paper
• Comparison of Recombinant Human Thyrotropin Receptors Versus Porcine Thyrotropin Receptors in the Thyrotropin Binding Inhibition Assay for Thyrotropin Receptor Autoantibodies

  1999cites this paper
• Two Graves' Disease Patients Who Spontaneously Developed Hypothyroidism After Antithyroid Drug Treatment: Characteristics of Epitopes for Thyrotropin Receptor Antibodies

  1999cites this paper
• Glycosylated ectodomain of the human thyrotropin receptor induces antibodies capable of reacting with multiple blocking antibody epitopes.

  1999cites this paper
• Epitope Heterogeneity of Thyrotropin Receptor-Blocking Antibodies in Graves' Patients as Detected with Wild-Type versus Chimeric Thyrotropin Receptors

  1999cites this paper
• Isolation of radiochemically pure 125I-labeled human thyrotropin receptor and its use for the detection of pathological autoantibodies in sera from Graves' patients.

  1999cites this paper
• Expansion of helper T-cell recognition in mice immunized with a synthetic peptide corresponding to the C-terminal thyrotropin receptor-specific insert.

  1999cites this paper
• Selective Binding of Thyrotropin Receptor Autoantibodies to Recombinant Extracellular Domain of Thyrotropin/Lutropin-Chorionic Gonadotropin Receptor Chimeric Proteins

  1999cites this paper
• Regulation of thyrotropin receptor protein expression in insect cells.

  1999influential citation
• Recognizing the Native Receptor Allows Production of Monoclonal Antibodies Thyrotropin Receptor Causes Thyroiditis and Genetic Immunization Against the Human

  1998cites this paper
• The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.

  1998cites this paper
• The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies

  1998cites this paper
• Immunization with the "immunogenic peptide" of TSH receptor induces oligoclonal antibodies with various biological activities.

  1998cites this paper
• Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor.

  1998cites this paper
• Bioassay of thyrotropin receptor antibodies with Chinese hamster ovary cells transfected with recombinant human thyrotropin receptor: clinical utility in children and adolescents with Graves disease.

  1998cites this paper
• Thyrotropin receptor epitopes recognized by graves' autoantibodies developing under immunosuppressive therapy.

  1998cites this paper
• The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies.

  1998influential citation
• Effect of solubilization of porcine thyrotropin (TSH) receptor on TSH binding and on radio-receptor assay for anti-TSH receptor antibodies.

  1998cites this paper
• Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population.

  1997cites this paper
• Graves' Disease Following Thyrotoxic Painless Thyroiditis. Analysis of Antibody Activities Against the Thyrotropin Receptor in Two Cases

  1997cites this paper
• Engineering the Human Thyrotropin Receptor Ectodomain from a Non-secreted Form to a Secreted, Highly Immunoreactive Glycoprotein That Neutralizes Autoantibodies in Graves’ Patients’ Sera*

  1997cites this paper
• Differential reactivities of recombinant glycosylated ectodomains of mouse and human thyrotropin receptors with patient autoantibodies.

  1997cites this paper
• Subtypes of Anti-TSH Receptor Antibodies Classified by Various Assays Using CHO Cells Expressing Wild-Type or Chimeric Human TSH Receptor

  1997influential citation
• Glycosylation variants of human TSH selectively activate signal transduction pathways.

  1997cites this paper
• Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease.

  1997cites this paper
• Flow cytometric analyses of antibody binding to Chinese hamster ovary cells expressing human thyrotropin receptor.

  1997cites this paper
• The TSH receptor

  1997cites this paper
• Requirement of glycosylation of the human thyrotropin receptor ectodomain for its reactivity with autoantibodies in patients' sera.

  1997cites this paper